SERB and Stark International’s $800 Million Acquisition of BTG Specialty Pharmaceuticals

Shearman & Sterling represented Boston Scientific in the transaction. Eight Advisory represented Serb. Mayer Brown represented Serb and Charterhouse. Boston Scientific executed the pending sale of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now